Showing results (21-30 of 644) with videos related to
Sort By:
Pageof 65
Biomarkers in Medicine|June 17, 2010
Biomarkers of inflammation and oxidative stress in atherosclerosisKiyoko Uno, Stephen J NichollsExpert Opinion on Drug Discovery|March 16, 2013
Effect of lipid-modifying therapies on the functional quality of high-density lipoproteins: implications for drug developmentMyngan Duong, Stephen J NichollsCurrent Medicinal Chemistry|April 17, 2014
New drugs for HDL-C disorders: the beginningMyNgan Duong, Stephen J NichollsCurrent Atherosclerosis Reports|January 16, 2014
Update in therapeutic approaches to plaque stabilizationStephen J Nicholls, Yu KataokaExpert Review of Cardiovascular Therapy|April 3, 2023
Lipoprotein(a): cardiovascular risk and emerging therapiesMasashi Fujino, Stephen J NichollsDiabetes & Vascular Disease Research|March 13, 2012
Peroxisome proliferator-activated receptor (PPAR α/γ) agonists as a potential target to reduce cardiovascular risk in diabetesStephen J Nicholls, Kiyoko UnoExpert Review of Cardiovascular Therapy|October 31, 2014
Imaging of atherosclerotic plaques in obesity: excessive fat accumulation, plaque progression and vulnerabilityYu Kataoka, Stephen J NichollsExpert Opinion on Drug Discovery|February 25, 2024
Perspectives on the success of plasma lipidomics in cardiovascular drug discovery and future challengesTimothy Abrahams, Stephen J NichollsCurrent Atherosclerosis Reports|February 15, 2025
Achieving More Optimal Lipid Control with Non-Statin Lipid Lowering TherapyStephen J Nicholls, Adam J NelsonEuropean Cardiology|May 11, 2026
The Impact of Current and Emerging Therapies on Lipoprotein(a)Stephen J Nicholls, Adam J NelsonPageof 65